Skip to content
HowShorted

Accendra Health, Inc. short interest in 2019

In 2019, Accendra Health, Inc.'s disclosed short interest ran from 17.79% of shares outstanding on 15 Jan 2019 to 17.09% on 31 Dec 2019, a change of -0.70 percentage points. The year's high was 19.87% on 28 Feb 2019 and its low 12.68% on 15 Nov 2019, averaging 17.38% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.21 days on 15 Jul 2019. Full history: Accendra Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accendra Health, Inc. in 2019

2019 in figures

Start of year
17.79% (15 Jan 2019)
End of year
17.09% (31 Dec 2019)
Change
-0.70 pp
High
19.87% (28 Feb 2019)
Low
12.68% (15 Nov 2019)
Average
17.38%
Highest days to cover
15.21 (15 Jul 2019)
SEC filings marked
8

Every report in 2019

Accendra Health, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201917.79%8.19
31 Jan 201918.40%6.61
15 Feb 201918.68%11.75
28 Feb 201919.87%4.23results (8-K)
15 Mar 201919.46%5.1810-K filed
29 Mar 201918.03%7.00
15 Apr 201917.53%6.37
30 Apr 201917.01%7.85
15 May 201918.21%8.0910-Q filed, results (8-K)
31 May 201919.58%8.36
14 Jun 201919.35%12.60
28 Jun 201918.23%8.50
15 Jul 201917.50%15.21
31 Jul 201917.41%11.91
15 Aug 201917.82%5.2310-Q filed, results (8-K)
30 Aug 201918.34%11.61
13 Sep 201917.43%3.88
30 Sep 201916.78%6.74
15 Oct 201915.32%5.38
31 Oct 201914.10%5.18
15 Nov 201912.68%4.6110-Q filed, results (8-K)
29 Nov 201914.50%7.35
13 Dec 201915.99%6.39
31 Dec 201917.09%7.16

See also: Accendra Health, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.